| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/10/2006 | CA2596618A1 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma |
| 08/10/2006 | CA2596514A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 08/10/2006 | CA2596424A1 Inhibitors of e1 activating enzymes |
| 08/10/2006 | CA2596357A1 Acid addition salts of ac-phscn-nh2 |
| 08/10/2006 | CA2596210A1 Combination therapies using hdac inhibitors |
| 08/10/2006 | CA2596178A1 Method for producing a drug extract that contains hydroxystilbene |
| 08/10/2006 | CA2596171A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
| 08/10/2006 | CA2595987A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer |
| 08/10/2006 | CA2595904A1 Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
| 08/10/2006 | CA2595834A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | CA2595792A1 Cd20 antibody variants and uses thereof |
| 08/10/2006 | CA2594717A1 Ibandronate polymorph b |
| 08/10/2006 | CA2594636A1 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | CA2593749A1 Classes of compounds that interact with integrins |
| 08/09/2006 | EP1688498A1 A recombinant protein with cancer suppression action, its encoding gene and use |
| 08/09/2006 | EP1688495A1 MU-1 member of the cytokine receptor family |
| 08/09/2006 | EP1688481A1 Bifidobacterium in the treatment of inflammatory disease |
| 08/09/2006 | EP1688439A1 Fused protein composition |
| 08/09/2006 | EP1688436A1 Composition of antibody capable of specifically binding ccr4 |
| 08/09/2006 | EP1688433A1 Antibody composition specifically binding to ganglioside gm2 |
| 08/09/2006 | EP1688432A1 Igm high concentration stabilized solution |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688429A1 Riproximin, a novel type II ribosome-inactivating protein and uses thereof |
| 08/09/2006 | EP1688419A1 Novel compound and medicinal composition |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688415A1 Cytotoxic agents comprising new C-2 modified taxanes |
| 08/09/2006 | EP1688147A1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon |
| 08/09/2006 | EP1688146A1 Preparing aldesleukin for pharmaceutical use |
| 08/09/2006 | EP1687631A1 Methods for identifying compounds involved in the phosphoinositide-mediated signalling and use thereof in the manufacture of medicaments |
| 08/09/2006 | EP1687449A2 Antisense modulation of kinesin-like 1 expression |
| 08/09/2006 | EP1687338A1 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor |
| 08/09/2006 | EP1687337A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 08/09/2006 | EP1687335A2 Cancer diagnosis and therapy |
| 08/09/2006 | EP1687313A1 Indolyl-thien 3,4-b]pyrazin-3-one derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 08/09/2006 | EP1687309A1 Pyrrolopyrimidine compounds useful in treatment of cancer |
| 08/09/2006 | EP1687305A1 1h-imidazoquinoline derivatives as protein kinase inhibitors |
| 08/09/2006 | EP1687304A1 Substituted quinolines for the treatment of cancer |
| 08/09/2006 | EP1687267A2 Modified mscl protein channel |
| 08/09/2006 | EP1687255A2 Calixarenes as inhibitors of protein kinase b |
| 08/09/2006 | EP1687027A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 08/09/2006 | EP1687013A1 Drug |
| 08/09/2006 | EP1686999A1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| 08/09/2006 | EP1686997A1 Inhibitors of the mutant form of kit |
| 08/09/2006 | EP1686995A1 Use of cathepsin k inhibitors for treating of severe bone loss diseases |
| 08/09/2006 | EP1686987A2 Advanced indolinone based protein kinase inhibitors |
| 08/09/2006 | EP1686982A2 Methods and compositions for the treatment of helicobacter pylori -associated diseases using endoperoxide bridge-containing compounds |
| 08/09/2006 | EP1686981A1 Combinational radiotherapy and chemotherapy compositions and methods |
| 08/09/2006 | EP1686961A1 Solid forms of anti-egfr-antibodies |
| 08/09/2006 | EP1597253B1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/09/2006 | EP1549951A4 Semaphorin-like proteins and methods of using same |
| 08/09/2006 | EP1549308B1 Protecting a patient from possible adverse effects of inhibition of the SHH- signaling pathway by suppressing testosterone |
| 08/09/2006 | EP1453949B1 Production of cell suspensions |
| 08/09/2006 | EP1448179B1 Substituted bicyclo 3.3.1 nonan-2,4,9-triones as pharmaceutical active ingredients |
| 08/09/2006 | EP1446124B1 Combination therapy comprising zd6474 and a taxane |
| 08/09/2006 | EP1441737B1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 08/09/2006 | EP1401806B1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1307481B1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 08/09/2006 | EP1267954B1 Medical devices suitable for gene therapy regimens |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1221940B1 Liposome formulation of 6,9-bis- (2-aminoethyl)-amino|benzo g|isoquinoline-5,10-dione dimaleate |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | EP1183275B1 Specific antibodies against human chorionic gonadotropin and their use in therapy and diagnostic |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | EP1148881B1 USE OF PYRIDAZINO ¬4,5-(b)|-INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS |
| 08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
| 08/09/2006 | EP1143981B1 Use of n-glycolneuraminic acid and its derivatives for the manufacture of a medicament for the treatment of hiv infections |
| 08/09/2006 | EP1135135A4 Chk1 kinase inhibitors |
| 08/09/2006 | EP1077722B1 Methods and products for inducing mucosal immunity |
| 08/09/2006 | EP1033979B1 Combination of cyp2a enzyme inhibitors and nicotine and their therapeutic use |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP1012177B1 Estrogen receptor |
| 08/09/2006 | EP1007098B1 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |
| 08/09/2006 | EP0920305B1 Identification of genes altered in multiple myeloma |
| 08/09/2006 | CN1816626A Antisense oligonucleotide having anticancerous activity |
| 08/09/2006 | CN1816564A Rasgap derived peptide for selectively killing cancer cells |
| 08/09/2006 | CN1816563A Polypeptides having binding affinity for HER2 |
| 08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 08/09/2006 | CN1816543A Indole derivatives with apoptosis-inducing effect |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816344A Herbal compositions for the treatment and prevention of prostate disorders |
| 08/09/2006 | CN1816338A Methods of treatment of chronic lymphocytic leukemia using roscovitine |
| 08/09/2006 | CN1816326A Composition of a VEGF antagonist and an anti-proliferative agent and usage in cancer treatment thereof |
| 08/09/2006 | CN1814621A Malania oeifera protein for human cancer treatment |
| 08/09/2006 | CN1814612A Ammonia maleate rubicin salt, and its preparing method and use |
| 08/09/2006 | CN1814600A Compound with antitumor activity, and its preparing method and use |
| 08/09/2006 | CN1814302A Method for selectively increasing tumor cell sensitivity to ionic radiation |
| 08/09/2006 | CN1814292A Anti-cancer prodrug, preparing method and use |
| 08/09/2006 | CN1814277A Use of methionine enkephalin in preparation of medicine for reducing toxic and side effect of chemical or radioactive therapy |
| 08/09/2006 | CN1814264A Jiangniling medicine of tonifying spleen and stomach for treating vomiting resulted by chemical therapy |
| 08/09/2006 | CN1814258A Chinese herbal medicine decoction for treating liver-cancer pain and preparing method |
| 08/09/2006 | CN1814246A Anti-tumor cancer-diminishing medicine and preparing method |
| 08/09/2006 | CN1814244A Chinese medicine suppository for treating liver fiberosis and hysteromyoma and preparing method |
| 08/09/2006 | CN1814222A Medicine for treating hysteromyoma |
| 08/09/2006 | CN1814153A Medicine composition for preventing and treating breast cancer and preparing method |
| 08/09/2006 | CN1814113A Medicine composition for treating hyperplasia of mammary glands and preparing technology |
| 08/09/2006 | CN1814034A Anti-cancer and cancer-preventing Chinese medicinal preparation |
| 08/09/2006 | CN1813967A Chinese medicine remedy for treating cancer of alimentany tract |